NEKTAR THERAPEUTICS — Director's Dealing 2018

Oct 2, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2018-09-27

Reporting Person: KUEBLER CHRISTOPHER A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-27	Common Stock	A	4750	$0.00	Acquired	45250	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-09-27	Stock Option	$60.91	A	9500	Acquired	2026-09-26	Common Stock (9500)	Direct

Footnotes

F1: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.

F2: This restricted stock unit award vests in full, one year following September 27, 2018.

F3: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2018.